Free Trial

EssilorLuxottica (ESLOY) Stock Forecast & Price Target

EssilorLuxottica logo
$147.77 -1.14 (-0.76%)
As of 08/1/2025 03:59 PM Eastern

EssilorLuxottica - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
0
Hold
1
Buy
0

Based on 1 Wall Street analysts who have issued ratings for EssilorLuxottica in the last 12 months, the stock has a consensus rating of "Hold." Out of the 1 analysts, 1 has given a hold rating for ESLOY.

Consensus Price Target

N/A

Get the Latest News and Ratings for ESLOY and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for EssilorLuxottica and its competitors.

Sign Up

ESLOY Analyst Ratings Over Time

TypeCurrent Forecast
8/2/24 to 8/2/25
1 Month Ago
7/3/24 to 7/3/25
3 Months Ago
5/4/24 to 5/4/25
1 Year Ago
8/3/23 to 8/2/24
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
0 Buy rating(s)
0 Buy rating(s)
0 Buy rating(s)
0 Buy rating(s)
Hold
1 Hold rating(s)
1 Hold rating(s)
1 Hold rating(s)
1 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price TargetN/AN/AN/AN/A
Forecasted UpsideN/AN/AN/AN/A
Consensus Rating
Hold
Hold
Hold
Hold

ESLOY Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

ESLOY Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

EssilorLuxottica Stock vs. The Competition

TypeEssilorLuxotticaMedical CompaniesS&P 500
Consensus Rating Score
2.00
2.81
2.53
Consensus RatingHoldModerate BuyModerate Buy
Predicted UpsideN/A10,407.36% Upside14.55% Upside
News Sentiment Rating
Positive News

See Recent ESLOY News
Neutral News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
1/29/2025Royal Bank Of Canada
4 of 5 stars
P. Dadhania
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Moderate Buy
12/3/2024UBS Group
3 of 5 stars
S. Tibaldi
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Neutral

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 12:30 PM ET.


Should I Buy EssilorLuxottica Stock? ESLOY Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Thursday, July 31, 2025. Please send any questions or comments about these EssilorLuxottica pros and cons to contact@marketbeat.com.

EssilorLuxottica
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in EssilorLuxottica Société anonyme:

  • The current stock price is around $148, reflecting a strong market interest and potential for growth.
  • EssilorLuxottica Société anonyme has recently experienced a significant increase in trading volume, indicating heightened investor activity and confidence.
  • The company has a diverse product portfolio, including well-known brands like Ray-Ban and Oakley, which can attract a wide customer base.
  • With a low debt-to-equity ratio, the company demonstrates financial stability, suggesting it is well-positioned to manage its obligations and invest in growth opportunities.
  • Recent developments in smart glasses technology could position the company favorably in a growing market, especially as major players like Meta invest in this area.

EssilorLuxottica
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in EssilorLuxottica Société anonyme for these reasons:

  • The company recently cut its dividend, which may signal financial strain or a shift in strategy that could concern income-focused investors.
  • Despite a strong brand presence, the competitive landscape in the eyewear industry is intense, which could impact market share and profitability.
  • Fluctuations in consumer spending, particularly in luxury goods, could adversely affect sales, especially during economic downturns.
  • The quick ratio of 0.65 indicates that the company may face challenges in meeting short-term liabilities, which could raise concerns about liquidity.
  • Market volatility can affect stock performance, and recent trading patterns suggest potential instability that may deter risk-averse investors.

ESLOY Forecast - Frequently Asked Questions

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for EssilorLuxottica in the last year. There is currently 1 hold rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" ESLOY shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ESLOY, but not buy additional shares or sell existing shares.

According to analysts, EssilorLuxottica's stock has a predicted downside of -100.00% based on their 12-month stock forecasts.

Analysts like EssilorLuxottica less than other "medical" companies. The consensus rating for EssilorLuxottica is Hold while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how ESLOY compares to other companies.


This page (OTCMKTS:ESLOY) was last updated on 8/2/2025 by MarketBeat.com Staff
From Our Partners